OtherCellular and Molecular
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavalda, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreno, Marisa Vinals, Teresa Domenech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesus Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics August 26, 2009, DOI: https://doi.org/10.1124/jpet.109.151639
Amadeu Gavalda
Montserrat Miralpeix
Israel Ramos
Raquel Otal
Cristina Carreno
Marisa Vinals
Teresa Domenech
Carla Carcasona
Blanca Reyes
Dolors Vilella
Jordi Gras
Julio Cortijo
Esteban Morcillo
Jesus Llenas
Hamish Ryder
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCellular and Molecular
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavalda, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreno, Marisa Vinals, Teresa Domenech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesus Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics August 26, 2009, DOI: https://doi.org/10.1124/jpet.109.151639
OtherCellular and Molecular
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavalda, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreno, Marisa Vinals, Teresa Domenech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesus Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics August 26, 2009, DOI: https://doi.org/10.1124/jpet.109.151639
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement